Defective pneumococcal-specific th1 responses in HIV-infected adults precedes a loss of control of pneumococcal colonization

Clinical Infectious Diseases

Volumn 56, Issue 2, 2013, Pages 291-299

  Glennie, Sarah J ^a,b   Banda, Dominic ^a   Gould, Kate ^c   Hinds, Jason ^c   Kamngona, Arox ^a   Everett, Dean D B ^a   Williams, Neil A ^d   Heyderman, Robert S ^a,b  

^a UNIVERSITY OF MALAWI   (Malawi)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Human; Mucosa; Streptococcus pneumoniae; HIV; T Cells

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; GAMMA INTERFERON; INTERLEUKIN 17;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL COLONIZATION; CD4+ T LYMPHOCYTE; CELL DISRUPTION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE CARRIER; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NASOPHARYNGEAL ASPIRATION; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; T CELL DEPLETION; TH1 CELL; TH17 CELL;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COINFECTION; COLONY COUNT, MICROBIAL; DISEASE PROGRESSION; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; TH1 CELLS; YOUNG ADULT;

EID: 84871775900     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis842     Document Type: Article

References (43)

1. Greenwood B. The epidemiology of pneumococcal infection in children in the developing world. Philos Trans R Soc Lond B Biol Sci 1999; 354:777-85. (Pubitemid 29365626)
2. O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009; 374:893-902.
3. Nunes MC, von Gottberg A, de Gouveia L, et al. The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis. AIDS 2011; 25:453-62.
4. Gray BM, Converse GM 3rd, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980; 142:923-33. (Pubitemid 11153261)
5. Auranen K, Ranta J, Takala AK, Arjas E. A statistical model of transmission of Hib bacteria in a family. Stat Med 1996; 15:2235-52. (Pubitemid 26394655)
6. Johnson HL, Deloria-Knoll M, Levine OS, et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med 2010; 10:7.
7. Turner P, Hinds J, Turner C, et al. Improved detection of nasopharyn-geal cocolonization by multiple pneumococcal serotypes by use of latex agglutination or molecular serotyping by microarray. J Clin Microbiol 2011; 49:1784-9.
8. Nesin M, Ramirez M, Tomasz A. Capsular transformation of a multi-drug-resistant Streptococcus pneumoniae in vivo. J Infect Dis 1998; 177:707-13. (Pubitemid 28099886)
9. Havarstein LS, Hakenbeck R, Gaustad P. Natural competence in the genus Streptococcus: evidence that streptococci can change pherotype by interspecies recombinational exchanges. J Bacteriol 1997; 179:6589-94. (Pubitemid 27465289)
10. Lipsitch M, Whitney CG, Zell E, et al. Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease? PLoS Med 2005; 2:e15.
11. Zhang Q, Choo S, Finn A. Immune responses to novel pneumococcal proteins pneumolysin, Psp A, Psa A, and CbpA in adenoidal B cells from children. Infect Immun 2002; 70:5363-9.
12. Zhang Q, Bernatoniene J, Bagrade L, et al. Regulation of production of mucosal antibody to pneumococcal protein antigens by T-cell-derived gamma interferon and interleukin-10 in children. Infect Immun 2006; 74:4735-43. (Pubitemid 44157261)
13. Lu YJ, Gross J, Bogaert D, et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 2008; 4: e1000159.
14. Pido-Lopez J, Kwok WW, Mitchell TJ, Heyderman RS, Williams NA. Acquisition of pneumococci specific effector and regulatory Cd4 T cells localising within human upper respiratory-tract mucosal lym-phoid tissue. PLoS Pathog 2011; 7:e1002396.
15. Kemp K, Bruunsgaard H, Skinhoj P, Klarlund Pedersen B. Pneumo-coccal infections in humans are associated with increased apoptosis and trafficking of type 1 cytokine-producing T cells. Infect Immun 2002; 70:5019-25.
16. Malley R, Trzcinski K, Srivastava A, et al. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci U S A 2005; 102:4848-53. (Pubitemid 40471542)
17. Malley R, Srivastava A, Lipsitch M, et al. Antibody-independent, in-terleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun 2006; 74:2187-95.
18. Milner JD, Brenchley JM, Laurence A, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008; 452:773-6. (Pubitemid 351521078)
19. Liang SC, Tan XY, Luxenberg DP, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006; 203:2271-9. (Pubitemid 44498362)
20. Medina MJ, Greene CM, Gertz RE, et al. Novel antibiotic-resistant pneumococcal strains recovered from the upper respiratory tracts of HIV-infected adults and their children in Kisumu, Kenya. Microb Drug Resist 2005; 11:9-17. (Pubitemid 40365838)
21. Gwanzura L, Pasi C, Nathoo KJ, et al. Rapid emergence of resistance to penicillin and trimethoprim-sulphamethoxazole in invasive Streptococcus pneumoniae in Zimbabwe. Int J Antimicrob Agents 2003; 21:557-61. (Pubitemid 36668009)
22. Buie KA, Klugman KP, von Gottberg A, et al. Gender as a risk factor for both antibiotic resistance and infection with pediatric serogroups/serotypes, in HIV-infected and-uninfected adults with pneumococcal bacteremia. J Infect Dis 2004; 189:1996-2000. (Pubitemid 38692278)
23. Scott JA, Hall AJ, Muyodi C, et al. Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet 2000; 355:1225-30. (Pubitemid 30184532)
24. Glennie SJ, Sepako E, Mzinza D, et al. Impaired CD4 T cell memory response to Streptococcus pneumoniae precedes CD4 T cell depletion in HIV-infected Malawian adults. PLoS One 2011; 6:e25610.
25. Iwajomo OH, Finn A, Moons P, et al. Deteriorating pneumococcal-specific B-cell memory in minimally symptomatic African children with HIV infection. J Infect Dis 2011; 204:534-43.
26. Mureithi MW, Finn A, Ota MO, et al. T cell memory response to pneumococcal protein antigens in an area of high pneumococcal carriage and disease. J Infect Dis 2009; 200:783-93.
27. Newton R, Hinds J, Wernisch L. Empirical Bayesian models for analysing molecular serotyping microarrays. BMC Bioinformatics 2011; 12:88.
28. Berry AM, Ogunniyi AD, Miller DC, Paton JC. Comparative virulence of Streptococcus pneumoniae strains with insertion-duplication, point, and deletion mutations in the pneumolysin gene. Infect Immun 1999; 67:981-5. (Pubitemid 29059247)
29. Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 1995; 333:845-51.
30. Jordano Q, Falco V, Almirante B, et al. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis 2004; 38:1623-8. (Pubitemid 38738561)
31. Glennie SJ, Williams NA, Heyderman RS. Mucosal immunity in resource-limited setting: is the battle ground different? Trends Microbiol 2011; 18:487-93.
32. Trzcinski K, Thompson C, Malley R, Lipsitch M. Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model. Infect Immun 2005; 73:7043-6. (Pubitemid 41368878)
33. Zhang Q, Leong SC, McNamara PS, et al. Characterisation of regulatory T cells in nasal associated lymphoid tissue in children: relationships with pneumococcal colonization. PLoS Pathog 2011; 7: e1002175.
34. Davenport V, Groves E, Hobbs CG, Williams NA, Heyderman RS. Regulation of Th-1 T cell-dominated immunity to Neisseria meningiti-dis within the human mucosa. Cell Microbiol 2007; 9:1050-61. (Pubitemid 46394914)
35. Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-59. (Pubitemid 39299461)
36. Weiss L, Donkova-Petrini V, Caccavelli L, et al. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004; 104:3249-56. (Pubitemid 39507143)
37. Angin M, Kwon DS, Streeck H, et al. Preserved function of regulatory T cells in chronic HIV-1 infection despite decreased numbers in blood and tissue. J Infect Dis 2012; 205:1495-1500.
38. Lee HY, Andalibi A, Webster P, et al. Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella ca-tarrhalis and nontypeable Haemophilus influenzae. BMC Infect Dis 2004; 4:12.
39. Dogan S, Zhang Q, Pridmore AC, et al. Pneumolysin-induced CXCL8 production by nasopharyngeal epithelial cells is dependent on calcium flux and MAPK activation via Toll-like receptor 4. Microbes Infect 2011; 13:65-75.
40. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198:962-70.
41. McCullers JA, Bartmess KC. Role of neuraminidase in lethal syner-gism between influenza virus and Streptococcus pneumoniae. J Infect Dis 2003; 187:1000-9. (Pubitemid 36337913)
42. McNamee LA, Harmsen AG. Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infect Immun 2006; 74:6707-21. (Pubitemid 44913145)
43. Nakamura S, Davis KM, Weiser JN. Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J Clin Invest 2011; 121:3657-65.